A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy
Conditions
- Major Depressive Disorder
Interventions
- DRUG: Aripiprazole 5mg
- DRUG: Aripiprazole 2mg
- DRUG: Placebo
Sponsor
Massachusetts General Hospital
Collaborators